We identified and validated a limited proteomic signature that discriminated VAP+ from VAP– patients comprised of three proteins: S100A8, lactotransferrin (LTF), and actinin 1 (ACTN1). The gene discussed is S100A8; the disease is ventilator-associated pneumonia.